Loading...
XASXDTZ
Market cap31mUSD
Jan 10, Last price  
0.09AUD
1D
1.11%
1Q
7.06%
Jan 2017
-70.65%
IPO
-100.00%
Name

Dotz Nano Ltd

Chart & Performance

D1W1MN
XASX:DTZ chart
P/E
—
P/S
585.14
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
24.54%
Rev. gr., 5y
20.79%
Revenues
53k
-80.84%
005,238,903113,759,343193,849,000205,701,000205,032,000182,731,00042,007,2470140,62920,61848,537545,892405,816276,81953,025
Net income
-10m
L+27.69%
01,310,397002,871,000-11,337,000-1,654,000-180,695,0000-8,089,937-6,173,249-7,683,083-5,391,196-5,765,252-10,573,183-7,751,157-9,897,269
CFO
-7m
L-2.41%
0000-5,860,00018,739,00018,557,00011,996,000-28,369,697-2,683,493-4,413,386-5,954,070-3,838,288-3,555,412-5,539,350-6,937,847-6,770,318
Earnings
Feb 27, 2025

Profile

Dotz Nano Limited engages in the development and marketing of carbon-based materials use in tracing, anti-counterfeiting, and product-liability solutions. It provides ValiDotz, BioDotz, Fluorensic, and InSpec solutions for various applications, such as anti-counterfeiting, brand and reputation protection, oil and gas industry, liquids tagging, lubricants, polymers tagging, and bio imaging. The company sells its products through distributors in North America, Europe, Japan, China, and Australia. It has scientific collaborations and partnerships with various academic institutes; and a collaboration agreement with Theracell Labs Ltd for the co-development, supply, and licensing of disposable bioprocessing consumables. Dotz Nano Limited is headquartered in Kfar Saba, Israel.
URL
https://www.dotz.tech/
IPO date
Dec 13, 2007
Employees
350
Domiciled in
AU
Incorporated in
AU

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
53
-80.84%
277
-31.79%
Cost of revenue
4,892
5,601
Unusual Expense (Income)
NOPBT
(4,839)
(5,324)
NOPBT Margin
Operating Taxes
(4)
Tax Rate
NOPAT
(4,839)
(5,324)
Net income
(9,897)
27.69%
(7,751)
-26.69%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,690
6,117
BB yield
-3.12%
-4.60%
Debt
Debt current
3,132
408
Long-term debt
711
2,889
Deferred revenue
Other long-term liabilities
106
2,259
Net debt
2,497
(1,199)
Cash flow
Cash from operating activities
(6,770)
(6,938)
CAPEX
(204)
Cash from investing activities
(1,046)
(391)
Cash from financing activities
3,622
5,851
FCF
(4,890)
(4,926)
Balance
Cash
1,346
4,496
Long term investments
Excess cash
1,343
4,482
Stockholders' equity
2,400
(361)
Invested Capital
4,416
5,279
ROIC
ROCE
EV
Common stock shares outstanding
478,845
443,711
Price
0.18
-40.00%
0.30
-34.78%
Market cap
86,192
-35.25%
133,113
-27.71%
EV
88,689
131,914
EBITDA
(4,839)
(4,807)
EV/EBITDA
Interest
1,089
716
Interest/NOPBT